Supplementing with the lactic acid bacterium Lactococcus lactis strain Plasma (LC-Plasma) can “alleviate fatigue accumulation caused by a continuous high training load,” a new randomised, double-blind, placebo-controlled study finds.
Nagasaki University and Kirin Holdings are embarking on a joint clinical research to assess the effect of lactic acid bacteria on relieving symptoms in COVID-19 human subjects.